Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 65.48
+0.50 (0.77%)
At close: May 12, 2026
Shanghai Medicilon Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -137.67 | -167.83 | -330.85 | -33.21 | 338.24 | 282.22 |
Depreciation & Amortization | 108.88 | 108.88 | 111.31 | 103.66 | 79.22 | 58.5 |
Other Amortization | 32.72 | 32.72 | 53.76 | 38.62 | 25.65 | 18.04 |
Loss (Gain) From Sale of Assets | 1.95 | 1.95 | 1.12 | 0.34 | 0.87 | 1.04 |
Asset Writedown & Restructuring Costs | 5.13 | 5.13 | 18.42 | - | 1.64 | 0.84 |
Loss (Gain) From Sale of Investments | -15.17 | -15.17 | -7.02 | -6.33 | -2.46 | - |
Provision & Write-off of Bad Debts | 66.23 | 66.23 | 110.45 | 44.07 | 21.86 | 7.68 |
Other Operating Activities | -16.13 | 19.81 | 30.18 | 27.26 | -3.65 | 5.89 |
Change in Accounts Receivable | 25.13 | 25.13 | -17.22 | -60.36 | -434.33 | -104.96 |
Change in Inventory | -15.64 | -15.64 | 45.21 | -11.69 | -87.64 | -50.79 |
Change in Accounts Payable | 82.77 | 82.77 | 10.05 | -45.19 | 8.11 | 203.04 |
Change in Other Net Operating Assets | -21.64 | -21.64 | 1.96 | 2.76 | 15.59 | 19.28 |
Operating Cash Flow | 99.4 | 105.17 | -22.75 | 33.32 | -21.33 | 452.94 |
Operating Cash Flow Growth | 170.52% | - | - | - | - | 118.00% |
Capital Expenditures | -93.24 | -69.03 | -110.39 | -185.68 | -404.06 | -292.71 |
Sale of Property, Plant & Equipment | 0.07 | 0.07 | 0.01 | 0.27 | - | 0.16 |
Cash Acquisitions | - | - | - | - | - | -7 |
Investment in Securities | 70.18 | 132.77 | 23.27 | -604.65 | 90 | -100 |
Other Investing Activities | 9.02 | 10.75 | -2.86 | 2.52 | 2.44 | - |
Investing Cash Flow | -13.96 | 74.56 | -89.97 | -787.55 | -311.62 | -399.55 |
Short-Term Debt Issued | - | - | - | - | 279 | - |
Long-Term Debt Issued | - | 360.08 | 320 | 457.1 | - | - |
Total Debt Issued | 269.22 | 360.08 | 320 | 457.1 | 279 | - |
Short-Term Debt Repaid | - | - | - | - | -50 | - |
Long-Term Debt Repaid | - | -512.48 | -379.48 | -357.74 | -20.19 | -13.9 |
Total Debt Repaid | -434.18 | -512.48 | -379.48 | -357.74 | -70.19 | -13.9 |
Net Debt Issued (Repaid) | -164.96 | -152.4 | -59.48 | 99.37 | 208.81 | -13.9 |
Issuance of Common Stock | 23.94 | 23.94 | - | 1,007 | 6.51 | 6.99 |
Repurchase of Common Stock | -50.09 | -50.09 | -40 | -19.99 | - | - |
Common Dividends Paid | -6.57 | -7.42 | -6.97 | -42.14 | -87.33 | -39.06 |
Other Financing Activities | 0.38 | - | -0.26 | -14.45 | -19.06 | -60 |
Financing Cash Flow | -197.3 | -185.97 | -106.71 | 1,030 | 108.94 | -105.97 |
Foreign Exchange Rate Adjustments | -5 | -2.11 | 6.13 | -0.19 | 8.17 | -0.99 |
Net Cash Flow | -116.85 | -8.34 | -213.3 | 275.34 | -215.84 | -53.58 |
Free Cash Flow | 6.16 | 36.14 | -133.14 | -152.36 | -425.39 | 160.22 |
Free Cash Flow Growth | - | - | - | - | - | 79.93% |
Free Cash Flow Margin | 0.49% | 3.11% | -12.83% | -11.16% | -25.64% | 13.73% |
Free Cash Flow Per Share | 0.05 | 0.27 | -0.99 | -1.19 | -3.50 | 1.32 |
Cash Income Tax Paid | - | -9.39 | -30.13 | -55.21 | 28.71 | -8.88 |
Levered Free Cash Flow | 0.84 | 160.81 | -78.05 | -159.98 | -583.36 | 14.51 |
Unlevered Free Cash Flow | 6.35 | 166.76 | -72.83 | -153.94 | -580.3 | 15.77 |
Change in Working Capital | 53.45 | 53.45 | -10.12 | -141.09 | -482.72 | 78.72 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.